Publication | Closed Access

Spironolactone suppresses aldosterone-induced Kv1.5 expression by attenuating mineralocorticoid receptor-Nox1/2/4-mediated ROS generation in neonatal rat atrial myocytes

Molecular PhysiologyMedicineVascular PharmacologyPhysiologyAldosterone-induced Kv1.5 ExpressionCardiovascular PharmacologyEndocrinologyPharmacologyCell BiologyPotassium HomeostasisOxidative Stress